Nick Latimer

I made a movie about survival analysis and #HTA! "What about a cure model?", set at Ultradrug Ltd. youtu.be/oc2J2hfCLJQ It's got a bit of KMunicate (@tmorris_mrc ), some stpm2 (@pclambert123, @MJRutherford9) and there's a special reward for anyone who makes it to the end

@BasarirH Thanks Hasan!

@NRLatimer lecturing us again (in the super informative, very clear way he always does!) about treatment switching, highlighting the new additions in TSD24 compared to the previous TSD16. Thanks Nick! #ISPOREurope

👩‍🏫 Join us at the #ISPORSummit for Prof. Nick Latimer's @NRLatimer talk on "Methods for Causal Inference Using Real-World Data " 📅 Sunday 17 November, 13:15 - 14:50. 💭 Enhance your #RWE knowledge with this insightful conversation. 🔗 buff.ly/3UGSSe2

@MJRutherford9 @UoL_Biostats @UoL_Health_Sci Great news and very much deserved, congratulations!

I found out last week that I'll be promoted to Professor from August. A good chance to reflect and to thank colleagues/students past & present @UoL_Biostats, in the wider department @UoL_Health_Sci & university, and also collaborators across the UK/world. + thanks for the cake...

Cure Models for HTA: What You Need to Know Should decision-makers be more willing to use cure models? How do they work? What can go wrong? What on earth are flexible parametric non-mixture cure models??! Thanks to @MJRutherford9 for writing this with me. link.springer.com/article/10.100…

We are currently advertising for an early career researcher with a strong background in statistics/mathematics and an interest in Bayesian statistics and health technology assessment to join us at @SCHARRSheffield G7, fixed-term until 31 March 2028 jobs.shef.ac.uk/sap/bc/webdynp…

Treatment switching in randomised controlled trials: Trial design, what to adjust for, how, and reporting guidelines. The DSU’s new TSD 24 provides an update to TSD 16 – out now! shorturl.at/uJKMO

A publication from my doctoral work with my fantastic and inspiring supervisors Prof Nick Latimer @NRLatimer and Prof Jim Chilcott, and sponsored by the generous @wellcometrust. @SCHARRSheffield @SCHARRHEDS #HTA #treatmentsequennces #RWD #causalinference

🚨 Helpful how-to evaluate treatment sequences for #HTA by @SCHARRSheffield Amy Chang @NRLatimer @ph_economics #pharmacoeconomics link.springer.com/article/10.100…

Research by @NRLatimer and colleagues shows that forcing a marginal hazard ratio to 1 does not accurately assess mean survival difference under individual-level treatment effect waning. More at ow.ly/gHFY50QO0yc. #HEOR #HTA #harzardratio #ValueinHealth

If you're too busy to read 4000 words on moving data between countries, listen to my quick summary of key points in the video below. @VivekSubbiah @NRLatimer #oncology

We are seeking leading cancer researchers to come & join us at Sheffield, in partnership with @SheffieldHosp. You'll have a package of support inc research staff, consumables & PhD(s) + access to dedicated funding opportunities through @yorkshirecancer 👉cancer-research-sheffield.co.uk

Some really great opportunities at Sheffield at the moment, including for methodologists.

📜Paper📜 in @BrainBehavior with @KRAbrams, @NRLatimer, @MichelaGuglieri, @MJRutherford9 and @Crowther_MJ. Assessing the CPRD as a data resource for DMD (and other rare disease) natural history models: ✅ Mortality ❓ Intermediate events doi.org/10.1002/brb3.3… #rarediseases

***Fully Funded PhD Studentships*** We have 7 @wellcometrust Studentships in Public Health Economics and Decision Science available. Check out our website for more information: pheds-dtc.ac.uk Deadline: 11th December 2023

📣 This time next week #ISPOREurope will be in full swing. 🔗 take a look at SCHARR's full academic programme buff.ly/3F5nwpb 😀 We hope you’ll pop by to see us on stand C2-021 in Hall E @ScHARRHEDS @ScHARRSheffield @ISPORorg #ISPOR2023

12 days left until #HWSmethods2023 in @uni_mainz! Check out the program👇 with keynotes from @nkreif and @NRLatimer. You can still register via herbstworkshop2023@proton.me - no participation fees thanks to @DGEpi_eV, @gmdsEV, @IBSstats, @DGSMP_e_V. #EpiTwitter #StatsTwitter

A big day 🤩 We've also launched: 👩‍🏫 A free course in survival analysis on our new Youtube channel 💻 A new #Stata package called #morgana for Bayesian flexible survival analysis 🧐 An advert for a new Principal Biostatistician to join the team #Biostatistics

Nice summary of our session ‘EHR - a good target’ which focussed on research design and methodologies for working with EHR. Great turnout and discussion #RSS2023Conf linkedin.com/posts/internat…

I'm delighted to announce publication of a new tutorial article on use of excess hazard models for HTA survival extrapolation with accompanying R and Stata code. Huge thanks to @MJRutherford9 @danj_statsguru @NRLatimer @pclambert123 and all co-authors doi.org/10.1177/027298…

A review of survival extrapolation methods with external evidence finds lots of methods, but little in the way of validation #hta #survivalanalysis @AshBullement @gianlubaio @gemmaeshields @NRLatimer @ScHARRHEDS @stats_UCL @HealthEcon_MCR bit.ly/423tcJG